Dr. John M Agaiby
Claim this profileClinical Investigation Specialists
Studies Type 2 Diabetes
Studies Diabetes
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials John M Agaiby is currently running
Lepodisiran
for Cardiovascular Disease
This trial is testing lepodisiran, a medication given as an injection under the skin. It targets people with high levels of lipoprotein(a) who have cardiovascular disease or are at risk of heart attack or stroke. The medication works by lowering lipoprotein(a) levels to reduce the risk of these cardiovascular events.
Recruiting1 award Phase 3
Orforglipron
for Type 2 Diabetes and Obesity
This trial is testing a new diabetes medication called orforglipron to see if it is safer and more effective than insulin in people with type 2 diabetes who are overweight or obese and at higher risk for heart problems. The study will last several years and involve multiple visits.
Recruiting2 awards Phase 3
More about John M Agaiby
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments John M Agaiby has experience with
- Tirzepatide
- Dulaglutide
- Orforglipron
- Insulin Glargine
- Lepodisiran
Breakdown of trials John M Agaiby has run
Type 2 Diabetes
Cardiovascular Disease
Chronic Kidney Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John M Agaiby specialize in?
John M Agaiby focuses on Type 2 Diabetes and Diabetes. In particular, much of their work with Type 2 Diabetes has involved treating patients, or patients who are undergoing treatment.
Is John M Agaiby currently recruiting for clinical trials?
Yes, John M Agaiby is currently recruiting for 2 clinical trials in Gurnee Illinois. If you're interested in participating, you should apply.
Are there any treatments that John M Agaiby has studied deeply?
Yes, John M Agaiby has studied treatments such as Tirzepatide, Dulaglutide, Orforglipron.
What is the best way to schedule an appointment with John M Agaiby?
Apply for one of the trials that John M Agaiby is conducting.
What is the office address of John M Agaiby?
The office of John M Agaiby is located at: Clinical Investigation Specialists, Gurnee, Illinois 60031 United States. This is the address for their practice at the Clinical Investigation Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.